<iframe src="//www.googletagmanager.com/ns.html?id=GTM-PLKVN8" height="0" width="0" style="display:none;visibility:hidden">
Navigation ▼

Breast Health Champions

These experts are paving the way in breast cancer detection, prevention and treatment.


BROUGHT TO YOU BY ALLIANCE CANCER SPECIALISTS

Sramila Aithal, MD

Medical Oncologist
Alliance Cancer Specialists

What new developments in breast cancer treatment are you excited about? There is now a large emphasis on specific targeted therapies for all stages of breast cancer which allows me to have an extremely per­sonalized treatment approach for my patients. This optimizes outcomes and reduces toxici­ties. For example, a recent addi­tional treatment option is the PARP inhibitor Olaparib, which extends disease-free survival in high-risk, early-stage breast cancer patients with germline BRCA1/2 mutations. The use of CD4/6 inhibitors in early and late stages of breast cancer is another exciting area. De-esca­lating axillary lymph nodal sur­gery continues to evolve and we are now using innovative ideas such as artificial intelligence in cancer diagnosis.

READ MORE


BROUGHT TO YOU BY CONSULTANTS IN MEDICAL ONCOLOGY AND HEMATOLOGY

Laura Austin, MD & Nabila Chowdhury, MD

Medical Oncologist and Hematologist & Medical Oncologist
Consultants in Medical Oncology and Hematology

What excites you most about advances in breast cancer treat­ment? NC: In many ways, the field of breast cancer has been the frontier in personalized cancer treatment. We have been pioneers in targeted therapy, and now we are integrating immu­notherapy into our treatment paradigm. We also continue to improve on our traditional chemo and hormonal therapies. It’s a testament to clinical research-and all of the brave women participating in it-that led us here. LA: Over time, we’ve come to understand that breast cancer is not this monolithic disease treated in a single way; it’s a collection of diseases. So as we learn more about the molecular underpinnings of breast cancer, we understand what drives them, and how to effectively treat them. There are different types, and each is treated differently, through various combinations of chemotherapy, immunotherapy, and endocrine therapy.

READ MORE


BROUGHT TO YOU BY CROZER HEALTH

Chantal Reyna, MD, FACS, FSSO

Medical Director of Breast Program and Chief of Breast Surgery
Crozer Health

What drew you to breast surgical oncology as a spe­cialty? The patients and the team-based approach. There is something truly rewarding about being with patients from their diagnosis to their survivorship years. It is a journey we take together. I found my calling into breast surgical oncology when I realized I spent my few free hours during training working with breast cancer patients and per­forming breast cancer research. After that, this has always been a passion and not a job. Growing up playing soccer and eventually becoming the inaugural gaol-keeper for the University of Nevada, Reno division one women’s soccer team, teamwork has always played an important role in my life. Breast cancer treatment is a team approach. I am fortunate to have found a career that combines my passion for patients and my love of teamwork.

READ MORE


BROUGHT TO YOU BY EINSTEIN MEDICAL CENTER PHILADELPHIA

Christin Collins, DO

Breast Surgical Oncologist
Einstein Medical Center Philadelphia

What drew you to focusing on breast diseases? My ini­tial exposure was when a friend’s mom was battling stage 4 breast cancer while we were in medical school. I had never witnessed advanced stages of cancer before. As I progressed through my sur­gical residency, a friend was diag­nosed with breast cancer at age 25, and she reached out to me for guidance. This ignited my quest for knowledge related to breast cancer and women’s health.

READ MORE